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Then 50 ml of contrast medium is injected very rapidly, simultaneously starting the cassette changer at one second intervals for 12 seconds. The films of the first 4 seconds visualize the portal vessels; this is the venogram phase and even small metastases are detected by deformity and truncating of these vessels. Between 5 and 12 seconds the media enters the parenchyma and produces the flush phase; metastases then show as negative shadows.
Cannulation of the umbilical vein has been used for fluid therapy, blood transfusion and parenteral feeding. It is postulated that cytotoxic drugs may be given by this route and their effect studied by portal venography at intervals. Infusions may contain antibiotics and this is an ideal route in cases of pylephlebitis. Finally, metabolic studies may be made of the portal blood. On completion, the catheter must be pulled out of the umbilical vein at the rate of half an inch (12 mm) a day to allow thrombosis along its tract. In 34 experiments using a Dale-Schuster pump, oxygenated Tyrode and dextran solution was infused without recirculation. Malignant cells were found in the local venous blood draining 20 tumours at the start of infusion. After 15-20 minutes, the venous effusate would be clear to the naked eye and the detection rate was positive in 5 cases only. Manipulation of the growth at this point did not liberate any cells but tumour cell release did occur in a further 10 cases (a total of 15 out of 20) after intra-arterial injection of streptokinase. Manipulation of the tumour at this stage caused further release of cells in 12 of these cases. Similar results were obtained in a group of 14 in whom malignant cells were not found in the local venous blood at the outset. In two small subgroups in this series venous dissemination after the injection of streptokinase was caused by (a) peristalsis induced by acetycholine (4 positive out of 7), and (b) a 10 minute period of anoxemia caused by the temporary cessation of infusion (4 positive out of 5).
Later modifications of apparatus and perfusion fluid achieved more physiological conditions, with recirculation of a perfusion fluid which contained red cells. Insufficient studies were made on the local venous blood at the start of perfusion but, after 15-20 minutes, tumour cells were detected in only 4 out of 36 cases. In the 32 negative cases, the injection of streptokinase caused a release of cells from 11 tumours and subsequent manipulation of the growth liberated malignant cells in 17 of 30 cases.
Under these experimental conditions tumour cells were released from two-thirds of the carcinomas (67 Y.) irrespective of the histological grade of malignancy. When the tumours were divided by Dukes' staging of spread, malignant cells could be released from 67 % of the B cases and from an insignificantly higher 72% of the C cases. There were only 7 A cases, and cells were liberated from only 3 of these. The detection rate did not appear to depend on the histological finding of venous invasion -67 % of tumours with venous invasion and 62 % of those without.
The source of malignant cells liberated into the blood stream is not known, but possible sites include the distended venous sinusoids at the edge of the tumour, in the submucosa and in the subserosal plexus. Tumour cell access to venous blood may be the result of direct invasion, intravasation (Cole et al. 1961, Dissemination of Cancer, Prevention and Therapy. New York) and lymphovenous communication in the regional nodes (Fisher & Fisher 1967 , Cancer (Philad.) 20,1907 .
The results reported here indicate that intravascular dissemination of carcinoma of the colon and rectum can be caused by a fibrinolytic agent and then be enhanced by tumour manipulation. This spread may be enhanced also by peristalsis and by tumour anoxia. Little is known of the normal variations in fibrinolytic activity within tumours or in the general circulation which may make such mechanisms important in the problem of clinical dissemination. Tumour cell embolus is not equivalent to metastasis, and in this series the in vitro detection of circulating malignant cells does not appear to be associated with any worse prognosis.
